key: cord-0753830-uwrghtr7 authors: Andreata‐Santos, Robert; Janini, Luiz M. R.; Durães‐Carvalho, Ricardo title: From Alpha to Omicron SARS‐CoV‐2 variants: What their evolutionary signatures can tell us? date: 2022-01-08 journal: J Med Virol DOI: 10.1002/jmv.27555 sha: d582e149c5172f019d0d3395fc86771544fef8f6 doc_id: 753830 cord_uid: uwrghtr7 nan , the concern about the potential increased spread and virulence of the Omicron variant is justified. Noteworthily, with the exception of S371L substitution, in a span of 12 months (October 2020-2021), all other mutations in Spike's RBD and RBM had been already described and predicted to promote different phenotypic characteristics (Table 1) . Further importance is given to the latter region (RBM) as it mediates the recognition to the human angiotensin-converting enzyme 2 receptors (ACE2) being, therefore, an important neutralizing antibody target 12, 13 (Figure 1 ). It is also worth mentioning that the low frequency of some substitutions in many virus strains is different from the emergence of the combination of these substitutions in a particular strain. We also found the additional Omicron Spike amino acid substitutions L141F, R346K, and V367F, also previously described. 3 The substitution L141F had not been cataloged by the World Health Organization (WHO) as present in this VOC. Furthermore, the substitution V367F is also not labeled by the WHO (i.e., "n/a") and, according to the European Centre for Disease Prevention and Control (ECDC) (https://www.ecdc.europa. eu/en/covid-19/variants-concern), it was first detected in the United 14, 15 The substitution Q498R appears to be epistatic to N501Y. 10 In view of the SARS-CoV-2 evolutionary signatures, it is also believed that such a proposition can be also addressed to other unidentified genetic lineages from the Greek alphabet which will prospectively label future SARS-CoV-2 variants. By providing useful insights into a linear vaccine perspective, we believe that these in- Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses Deep phylogenetic-based clustering analysis uncovers new and shared mutations in SARS-CoV-2 variants as a result of directional and convergent evolution. medRxiv Molecular architecture of early dissemination and massive second wave of the SARS-CoV-2 virus in a major metropolitan area Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies In silico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. eLife Structural modeling of the SARS-CoV-2 spike/ human ACE2 complex interface can identify high-affinity variants associated with increased transmissibility SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution Molecular rationale for SARS-CoV-2 spike circulating mutations able to escape bamlanivimab and etesevimab monoclonal antibodies SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2 Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis Emergence of genomic diversity and recurrent mutations in SARS-CoV-2 Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant Unipro UGENE: a unified bioinformatics toolkit Additional supporting information may be found in the online version of the article at the publisher's website.